2019
Association Between Power Morcellation and Mortality in Women With Unexpected Uterine Cancer Undergoing Hysterectomy or Myomectomy.
Xu X, Lin H, Wright JD, Gross CP, Boscoe FP, Hutchison LM, Schwartz PE, Desai VB. Association Between Power Morcellation and Mortality in Women With Unexpected Uterine Cancer Undergoing Hysterectomy or Myomectomy. Journal Of Clinical Oncology 2019, 37: 3412-3424. PMID: 31518176, PMCID: PMC6901279, DOI: 10.1200/jco.19.00562.Peer-Reviewed Original ResearchConceptsTotal abdominal hysterectomyOccult uterine sarcomaUncontained power morcellationDisease-specific mortalityOccult uterine cancerSupracervical abdominal hysterectomyPower morcellationOccult endometrial carcinomaAbdominal hysterectomyUterine sarcomaUterine cancerEndometrial carcinomaMortality riskMultivariable Cox regressionPrognosis of patientsSubset of womenTime of hysterectomyHospital discharge recordsCancer registry dataHigher mortality riskOccult leiomyosarcomaCause mortalityLaparoscopic myomectomyPatient characteristicsBenign indicationsRisk of unexpected uterine Cancer in women undergoing myomectomy: A population-based study
Desai VB, Wright J, Gross C, Lin H, Boscoe F, Schwartz P, Xu X. Risk of unexpected uterine Cancer in women undergoing myomectomy: A population-based study. European Journal Of Obstetrics & Gynecology And Reproductive Biology 2019, 238: 188-190. PMID: 31103353, DOI: 10.1016/j.ejogrb.2019.03.021.Peer-Reviewed Original Research
2018
In Reply
Desai VB, Wright JD, Schwartz PE, Gross CP, Xu X. In Reply. Obstetrics And Gynecology 2018, 132: 519-520. PMID: 30045198, DOI: 10.1097/aog.0000000000002770.Peer-Reviewed Case Reports and Technical NotesOccult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications
Desai VB, Wright JD, Schwartz PE, Jorgensen EM, Fan L, Litkouhi B, Lin H, Gross CP, Xu X. Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications. Obstetrics And Gynecology 2018, 131: 642-651. PMID: 29528920, DOI: 10.1097/aog.0000000000002521.Peer-Reviewed Original ResearchConceptsCorpus uteriCervix uteriOvarian malignancyBenign indicationsSurgical routeSurgeons National Surgical Quality Improvement ProgramNational Surgical Quality Improvement ProgramLaparoscopic-assisted vaginal hysterectomySurgical Quality Improvement ProgramLaparoscopic supracervical hysterectomyPrimary outcome measureBeginning of surgeryLogistic regression analysisQuality Improvement ProgramTotal laparoscopicPatient agePatient characteristicsSupracervical hysterectomyVaginal hysterectomyGynecologic cancerUndetected malignancyOvarian cancerHysterectomyOutcome measuresAmerican College
2015
Alterations in surgical technique after FDA statement on power morcellation
Desai VB, Guo XM, Xu X. Alterations in surgical technique after FDA statement on power morcellation. American Journal Of Obstetrics And Gynecology 2015, 212: 685-687. PMID: 25735888, DOI: 10.1016/j.ajog.2015.02.027.Peer-Reviewed Original Research